{"id":70544,"date":"2020-01-17T07:23:48","date_gmt":"2020-01-17T06:23:48","guid":{"rendered":"https:\/\/renewable-carbon.eu\/news\/?p=70544"},"modified":"2020-01-14T12:25:11","modified_gmt":"2020-01-14T11:25:11","slug":"european-synthetic-biology-company-octarine-receives-funding-to-develop-biosynthetic-platform-for-cannabinoid-and-psilocybin-derivatives","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/european-synthetic-biology-company-octarine-receives-funding-to-develop-biosynthetic-platform-for-cannabinoid-and-psilocybin-derivatives\/","title":{"rendered":"European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives"},"content":{"rendered":"

Today, Octarine Bio IVS (\u201cOctarine\u201d or the \u201cCompany\u201d), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial fermentation announce a successful fundraising from private investors including Oskare Capital and Canopy Growth Cooperation (\u201cCanopy Growth\u201d) former CEO and founder Bruce Linton. Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX), included on a major stock index (S&P\/TSX Composite Index) and to list on the New York Stock Exchange.<\/strong><\/p>\n

\u201cWe\u2019re thrilled to have the backing of a pioneer in the cannabis industry\u201d says Nethaji Gallage, CEO of Octarine. \u201cBruce\u2019s expertise, network, and knowledge will be a valuable asset to us, and we look forward to accelerating our technology with his and our other private investors\u2019 support\u201d.<\/p>\n

\u201cOctarine is a promising young company with a platform technology that can accelerate several rapidly evolving sectors, including work on synthesizing rare and novel cannabinoids\u201d says Bruce Linton. \u201cI look forward to supporting the Company and seeing their technology utilized in the market\u201d.<\/p>\n

The new funds will be used to strengthen the Company\u2019s existing intellectual property and to demonstrate the commercial scalability of its fermentation-based production platform. Octarineis currently raising a seed round expected to close in early 2020.<\/p>\n

 <\/p>\n

About Octarine<\/h3>\n

Octarine\u2019s mission is harnessing synthetic biology to develop rare and functionally superior cannabinoids and psilocybin derivatives targeting the pharmaceutical industry to improve the health and well-being of people worldwide. Octarine has developed in-cell enzymatic platforms expanding the chemical diversity of cannabinoids and psychedelic tryptamine derivatives facilitating the production of superior molecules with improved pharmacokinetic properties.<\/p>\n

About Bruce Linton<\/h3>\n

Mr. Linton is the founder and former CEO of Canopy Growth and co-founder of Tweed Marijuana Incorporated. Under Mr. Linton’s leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange. Mr. Linton held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp., and part of the establishing team at CrossKeys Systems Corporation (“CrossKeys”). He was also part of the leadership team for the NASDAQ\/TSX initial public offering at CrossKeys.<\/p>\n

 <\/p>\n

Contact<\/h3>\n

Nethaji Gallage, Octarine CEO
\nPhone: +45 276 393 53
\nE-Mail: nethaji@octarinebio.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Today, Octarine Bio IVS (\u201cOctarine\u201d or the \u201cCompany\u201d), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial fermentation announce a successful fundraising from private investors including Oskare Capital and Canopy Growth Cooperation (\u201cCanopy Growth\u201d) former CEO and founder Bruce Linton. Canopy Growth was the first cannabis producing company in North America […]<\/p>\n","protected":false},"author":59,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[12268,13012],"supplier":[16569,14602,24048],"class_list":["post-70544","post","type-post","status-publish","format-standard","hentry","category-bio-based","tag-cannabis","tag-phytopharmaceuticals","supplier-bruce-linton","supplier-canopy-growth","supplier-octarine-bio"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/70544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=70544"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/70544\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=70544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=70544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=70544"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=70544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}